Headache & Migraine
Conference Coverage
Visual snow: Alarming and not uncommon
As many as 3% of the population may experience this visual abnormality, but it’s usually benign.
Conference Coverage
Headache is a common post–COVID-19 complaint
The condition may be new onset or an exacerbation an existing condition, and should raise suspicion of COVID-19 infection.
Literature Review
Erenumab beats topiramate for migraine in first head-to-head trial
The findings suggest that erenumab may help overcome longstanding issues with migraine medication adherence.
Literature Review
Largest ever review of new daily persistent headache assesses its clinical features
“Future prospective studies are needed to better understand this disabling disorder.”
Conference Coverage
DIY nerve stimulation effective in episodic migraine
Participants in a new study applied neurostimulation for a continuous 2-hour period within 4 hours of a migraine attack.
Conference Coverage
Pandemic survey: Forty-six percent of pediatric headache patients got worse
But some fared better when they were stuck at home instead of at school.
News
FDA okays new oral CGRP antagonist for migraine prevention
With this approval, neurologists will be able to choose from four monoclonal antibodies and two gepants for the preventive treatment of migraine...
News
Assessing headache severity via migraine symptoms can help predict outcomes
“Our hope is that this work serves as foundational basis for better understanding the complexity of headache as a symptom-based condition.”
News
Atogepant reduces migraine days: ADVANCE trial results published
“Overall, this study showed us that atogepant was safe and surprisingly seems to be pretty effective regardless of the dose.”
News
Headache seen affecting some pregnancy outcomes
A new study links migraine – and also tension-type headache – to small-for-gestational-age babies.